State Street Corp Argenx Se Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Argenx Se stock. As of the latest transaction made, State Street Corp holds 2,586 shares of ARGX stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,586

Previous 2,720 4.93%

Holding current value

$1.46 Million

Previous $1.17 Million 19.93%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$434.22 - $551.9 $58,185 - $73,954	-134 Reduced 4.93%	2,586 $1.4 Million
Q2 2024 Aug 14, 2024	BUY	$356.01 - $451.55 $43,077 - $54,637	121 Added 4.66%	2,720 $1.17 Million
Q1 2024 May 15, 2024	BUY	$356.95 - $413.29 $3,569 - $4,132	10 Added 0.39%	2,599 $1.02 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $33,891 - $50,601	100 Added 4.02%	2,589 $984,000
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $35,826 - $53,197	97 Added 4.06%	2,489 $1.22 Million
Q2 2023 Aug 14, 2023	SELL	$360.14 - $422.58 $46.7 Million - $54.8 Million	-129,644 Reduced 98.19%	2,392 $932,000
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $43.2 Million - $52.2 Million	129,396 Added 4901.36%	132,036 $49.2 Million
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $129,340 - $152,073	-378 Reduced 12.52%	2,640 $1 Million
Q3 2022 Nov 15, 2022	BUY	$343.2 - $395.75 $123,895 - $142,865	361 Added 13.59%	3,018 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $218,359 - $306,892	810 Added 43.85%	2,657 $1.01 Million
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $20,864 - $28,786	-82 Reduced 4.25%	1,847 $582,000
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $21,216 - $27,536	78 Added 4.21%	1,929 $676,000
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $14.5 Million - $17.2 Million	-49,014 Reduced 96.36%	1,851 $557,000
Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $1.28 Million - $1.59 Million	-4,968 Reduced 8.9%	50,865 $15.3 Million
Q1 2021 May 17, 2021	BUY	$268.3 - $380.31 $14.3 Million - $20.2 Million	53,162 Added 1990.34%	55,833 $15.4 Million
Q4 2020 Feb 16, 2021	SELL	$248.13 - $308.36 $6.5 Million - $8.07 Million	-26,185 Reduced 90.74%	2,671 $789,000
Q3 2020 Nov 10, 2020	BUY	$215.51 - $272.51 $5.87 Million - $7.43 Million	27,257 Added 1704.63%	28,856 $7.58 Million
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $203,776 - $372,119	1,599 New	1,599 $360,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Argenx Se Transaction History